Company: LDDD
Filing Date: 2025-09-26
Form Type: 10-K
Source: 0001213900-25-091988
Chunk: 315

Company: Longduoduo Co Ltd
Filing Date: 2025-09-26
Form: 10-K
Item: Item 3
Chunk 315
---
.

●Beijing
Julong Health Consulting Co., Limited (“Julong”) was established in Beijing, China on July 23, 2024. LDDJK has controlled
100% of Julong since its inception.

●Beijing
Yihua Health Consulting Co., Limited (“Yihua”) was established in Beijing, China on March 14, 2024. On January 7, 2025, Julong
acquired all the shares held by the original shareholders of Yihua, and controlled 100% ownership of Yihua.

●Longduoduo
Health Technology Company Limited (“Longduoduo Health Technology”) is a privately held Limited Company, registered in Inner
Mongolia, China on August 20, 2020. On August 16, 2021, Longduoduo HK acquired 100% of Longduoduo Health Technology from the original
shareholders of Longduoduo Health Technology. On April 2, 2025, Julong acquired 100% of Longduoduo Health Technology from Longduoduo
HK.

●Inner
Mongolia Qingguo Health Consulting Company Limited (“Qingguo”) is a privately held Limited Company, registered in Inner Mongolia,
China on June 18, 2020. On September 8, 2020, Longduoduo Health Technology acquired 90% of Qingguo from the original shareholders of
Qingguo.

●Inner
Mongolia Rongbin Health Consulting Company Limited (“Rongbin”) is a privately held Limited Company, registered in Inner Mongolia,
China on March 18, 2021. Longduoduo Health Technology has controlled 80% of Rongbin since its inception.

●Inner
Mongolia Chengheng Health Consulting Company Limited (“Chengheng”) is a privately held Limited Company, registered in Inner
Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of Chengheng since its inception.

●Inner
Mongolia Tianju Health Consulting Company Limited (“Tianju”) is a privately held Limited Company registered in Inner Mongolia,
China on July 5, 2021. Longduoduo Health Technology has controlled 51% of Tianju since inception.

The
transactions summarized above are treated in the Company’s financial statements as a corporate restructuring (reorganization) of
entities under common control, as each of the